Which patents cover Briellyn, and what substitute generic drugs are available?Briellyn is a drug marketed by Glenmark Generics and is included in one NDA.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
ethinyl estradiol; norethindrone
|TABLET;ORAL-28||090538-001||Mar 22, 2011||RX||No||No||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.